NovoCure NVCR Ratios (2014-2026)

NASDAQ NVCR
$15.59 -0.12 (-0.76%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

NovoCure Quarterly Ratios

Periods 48 quarters
Latest Jun 2026

NovoCure reported a gross margin of 77.61% and a net margin of -8.53% for the quarter ended Jun 2026. These financial ratios cover 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
77.39%77.71%79.84%79.77%77.29%77.51%75.76%73.01%74.79%75.67%75.68%76.95%77.19%79.25%75.15%73.88%73.25%75.82%77.63%77.61%
EBT Margin
-7.88%-19.20%-1.83%-16.58%-17.88%-25.35%-41.81%-42.76%-37.87%-28.80%-22.85%-15.12%-13.92%-34.23%-19.55%-22.03%-17.96%-23.49%-39.79%-6.78%
EBIT Margin
-6.40%-17.56%-0.59%-15.00%-18.79%-33.46%-49.31%-49.71%-45.75%-38.66%-29.98%-22.33%-20.69%-39.25%-24.43%-24.89%-21.54%-23.17%-38.73%-5.75%
EBITDA Margin
-3.77%-14.97%1.81%-12.53%-16.58%-33.92%-50.40%-51.58%-48.80%-42.05%-31.83%-24.99%-23.45%-41.47%-26.58%-26.79%-23.18%-22.90%-37.87%-4.82%
Operating Margin
-6.40%-17.56%-0.59%-15.00%-18.79%-33.46%-49.31%-49.71%-45.75%-38.66%-29.98%-22.33%-20.69%-39.25%-24.43%-24.89%-21.54%-23.17%-38.73%-5.75%
Net Margin
-9.82%-19.86%-3.38%-17.04%-20.29%-29.05%-43.43%-45.55%-38.87%-35.19%-27.98%-22.20%-19.71%-40.88%-22.14%-25.28%-22.29%-14.05%-40.87%-8.53%
FCF Margin
15.79%0.10%-6.38%8.26%12.76%-7.89%-18.67%-23.54%-20.87%-15.98%-31.30%-8.76%-0.20%-7.68%-29.86%-13.49%8.92%-13.13%-10.73%0.66%
Efficiency
Inventory AverageInventory Avg.
24.67M23.53M26.76M29.31M28.16M28.08M30.55M32.37M34.91M37.48M40.27M41.42M39.77M37.09M37.28M39.84M39.66M40.11M42.28M42.84M
Assets AverageAssets Avg.
1,108.76M1,129.97M1,144.85M1,156.44M1,168.44M1,182.93M1,182.99M1,166.68M1,152.68M1,146.24M1,133.78M1,166.80M1,217.08M1,231.39M1,244.80M1,247.34M1,303.53M1,082.76M796.13M791.56M
Equity AverageEquity Avg.
405.22M411.83M423.19M438.78M443.54M443.29M436.66M423.91M404.69M378.10M360.93M360.55M361.27M360.48M361.07M355.70M345.39M340.90M335.59M334.40M
Invested CapitalInvested Cap.
974.55M972.71M998.91M1,005.52M1,010.08M1,006.68M998.47M982.83M961.69M362.50M929.01M458.71M1,015.26M1,015.64M1,018.38M1,006.84M1,096.59M535.51M526.18M533.98M
Asset Utilization RatioAsset Util.
0.490.470.470.470.460.450.440.440.440.440.460.470.470.490.500.510.490.610.850.88
Leverage & Solvency
Interest Coverage RatioInterest Cover
-4.32-10.76-0.47-9.48
Debt Ratio
0.500.490.490.480.480.470.480.490.500.510.080.540.530.530.530.550.240.250.25
Times Interest Earned
-4.32-10.76-0.47-9.48
Valuation
Price to EarningsP/E
Price to SalesP/S
22.1014.5916.1113.3514.6914.3312.228.713.423.143.203.362.925.343.203.162.252.221.872.52
Price to BookP/B
29.1919.0219.8716.4817.9017.4714.7810.644.384.414.685.114.688.985.495.694.244.273.825.22
Enterprise Value
11,126.70M6,868.46M7,730.42M6,330.06M7,003.25M6,735.95M5,428.06M3,483.31M802.74M688.03M811.70M899.09M729.71M2,273.93M1,057.49M1,078.49M413.28M1,006.86M830.44M1,323.54M
EV to EBIT
EV to EBITDA
0.00M
Market Capitalization
12,060.49M7,806.16M8,662.72M7,278.57M7,973.57M7,705.37M6,386.10M4,424.12M1,723.98M1,598.64M1,681.85M1,850.28M1,689.61M3,233.80M1,986.62M1,990.02M1,446.78M1,454.53M1,262.45M1,764.10M
Price to FCFP/FCF
113.59133.24240.58302.22404.79817.11
EV to FCF
104.79117.24214.69262.83355.53714.31
EV to CFO
91.3383.00126.13124.41143.22218.78305.84
Return Ratios
Return on Sales [ROS]ROS
-6.40%-17.56%-0.59%-15.00%-18.79%-33.46%-49.31%-49.71%-45.75%-38.66%-29.98%-22.33%-20.69%-39.25%-24.43%-24.89%-21.54%-23.17%-38.73%-5.75%
Return on Capital Employed [ROCE]ROCE
-0.90%-4.49%-4.43%-5.28%-6.81%-8.74%-14.40%-18.74%-22.51%-24.08%-22.00%-18.55%-32.96%-35.89%-33.27%-34.72%-33.50%-17.89%-31.69%-27.05%
Return on Invested Capital [ROIC]ROIC
-0.92%-4.55%-4.57%-5.38%-6.94%-8.88%-14.86%-19.23%-23.05%-35.17%-33.16%-26.67%-21.56%-16.79%-16.41%-17.06%-16.80%-18.84%-34.11%-28.34%
Return on Assets [ROA]ROA
-2.43%-5.16%-5.14%-5.90%-6.99%-7.82%-11.91%-14.94%-17.11%-18.06%-17.00%-14.46%-12.31%-13.69%-13.19%-13.71%-13.63%-12.58%-21.74%-18.77%
Return on Equity [ROE]ROE
-6.66%-14.17%-13.91%-15.55%-18.42%-20.87%-32.28%-41.13%-48.74%-54.76%-53.40%-46.79%-41.46%-46.78%-45.47%-48.06%-51.44%-39.96%-51.56%-44.43%

NovoCure Ratios API

Pull NovoCure's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVCR&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY